Archive for the ‘Celladon’ Category

Celladon

January 9th, 2015 | Posted in 2014, Celladon

Celladon, San Diego, was added to the Nasdaq Biotechnology Index (Nasdaq: CLDN) just 11 months after entering the stock market. Celladon is a clinical-stage firm specializing in the development of cardiovascular gene therapy.